Aug 24, 2020 Roth Capital Partners acts as Sole Manager for Fathom Holdings Inc. (NASDAQ: FTHM) in its $34.3 Million IPO Roth Capital Partners
Aug 20, 2020 Roth Capital Partners acts as Sole Placement Agent for MediPharm Labs Corp. (TSX: LABS) in its CAD$37.8 Million Private Placement Roth Capital Partners
Aug 18, 2020 Roth Capital Partners Acts as Joint Book-Running Manager for Quhuo Limited (NASDAQ: QH) in its $37.9 Million IPO Roth Capital Partners
Aug 14, 2020 ROTH Capital Partners acts as Sole Book-Running Manager for Rimini Street, Inc. (Nasdaq: RMNI) in its $27.5 Million Follow-On Roth Capital Partners
Aug 4, 2020 Roth Capital Partners Acts as Sole Placement Agent for Tellurian, Inc. (NASDAQ: TELL) in its $35 Million Registered Direct Offering Roth Capital Partners
Jul 23, 2020 Roth Capital Partners Acts as Co-Manager for Atreca, Inc. (Nasdaq: BCEL) in its $125 Million Follow-On Roth Capital Partners
Jul 22, 2020 Roth Capital Partners Acts as Co-Manager for Altimmune, Inc. (Nasdaq: ALT) in its $132.3 Million Follow-On Roth Capital Partners
Jul 21, 2020 Roth Capital Partners Acts as Co-Manager for Inventiva S.A. (Nasdaq: IVA & Euronext Paris: IVA) in its $107.7 Million U.S. IPO Roth Capital Partners
Jul 8, 2020 ROTH Capital Partners Announces the Addition of Elemer Piros, Ph.D. to its Healthcare Business Wire
Jul 7, 2020 Roth Capital Partners acts as Co-Manager for CRISPR Therapeutics (Nasdaq:CRSP) in its $517.5 Million Follow-On Roth Capital Partners
